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INTRODUCTION
 Acute renal injury after exposure to iodinated 
contrast media increases morbidity, hospital stay 
and early mortality.1 Contrast-induced acute 
renal damage is an important clinical event with 
an international increasing number of cases.2,3 
Contrast-induced nephropathy (CIN) occurs 
in 2% to 25% of patients undergoing coronary 
intervention.2,3 CIN is defined as increase in serum 
creatinine of 0.5 mg/dL, or a 25% relative increase 
in creatinine at 48 hours after contrast exposure.1-4 
The pathophysiology of CIN is a complex interplay 
between vascular and tubular effects. Tubular 
toxicity, generation of reactive oxygen species and 
medullary blood flow reduction are suggested as 
being the risk factors of CIN.1-4 After the infusion 
of contrast agents, osmotic load, hypoxemia of 
the renal medulla, viscosity and renal free radical 
production via post-ischemic oxidative stress will 
increase.2-4 While reactive oxygen species (ROS) 
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ABSTRACT
Background and Objective:	Reactive	oxygen	species	(ROS)	is	a	mediator	of	renal	damage.	Melatonin	is	
a	potent-free	radical	scavenger.	Our	objective	was	to	test	whether	melatonin	would	protect	against	the	
nephrotoxicity	of	contrast	media.
Methods: In	an	experimental	study	40	adult	male	Wistar	rats	were	randomly	divided	into	four	equal	groups	
including:	1)	Control	group	(No	drug),	2)	Contrast	media	group	(10	ml/kg	 iodixanol	 i.v.	single	dose),	3)	
Contrast	media	and	melatonin	(first	10	ml/kg	iodixanol	then	10	ml/kg/day	melatonin	by	i.p.	injection	on	
days	3,	4	and	5)	and	4)	Contrast	media	and	melatonin	pretreatment	group	(melatonin	10	ml/	kg/day	by	i.p.	
injection	on	1,	2	and	3	days,	then	10	ml/kg	iodixanol	by	i.v.	injection	on	third	day.	The	blood	creatinine	
and	BUN	as	well	as	 the	histological	changes	were	evaluated	for	severity	of	 renal	 injury	 (degeneration,	
vacuolization	of	tubular	renal	cells,	dilatation	of	tubular	lumen	and	presence	of	debris	in	the	lumens),	by	
scoring	from	one	to	four.
Results: Contrast	 media	 significantly	 increased	 the	 creatinine	 and	 BUN	 and	 renal	 injury	 (p	 <	 0.05).	
Melatonin	prevented	and	 reversed	 the	 injury	 induced	by	contrast	media	 (P	<	0.05).	Pretreatment	with	
melatonin	reduced	the	renal	injury	induced	by	contrast	media	(P	<	0.05).
Conclusion: Melatonin	is	an	effective	drug	to	prevent	contrast–induced	renal	injury.	Therefore	its	usage	
(especially	pretreatment)	might	be	beneficial	in	patients	who	are	planning	to	use	contrast	media	agents.
KEY WORDS:	 Contrast-induced	 nephropathy,	 Contrast	 media,	 Iodixanol,	 Melatonin,	 Reactive	 oxygen	
species,	Renal	failure.
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have been increasingly found as the mediator 
of renal damage CIN, however renal medullary 
hypoxia is indisputable to the pathophysiology 
of this disease.2-5 The outer medulla is especially 
susceptible to hypoxia; oxygen necessities are high 
due to salt reabsorption in Henle’s thick ascending 
limbs, while oxygen supply is scant.4,5 Contrast 
agents in the medulla affect the delicate balance 
between oxygen delivery and oxygen consumption 
by several mechanisms, the main mechanism 
being reduced blood perfusion. In both the cortex 
and the medulla, contrast agents can shift the 
balance between vasodilatory and vasoconstrictive 
substances towards vasoconstriction.3-5
 Melatonin (N-acetyl-5-methoxytryptamine) is a 
secretory product of the pineal gland. It acts through 
melatonin receptors, to do various physiological 
processes including circadian entrainment, 
seasonal reproduction, retinal physiology, ovarian 
physiology, immune function, blood pressure 
regulation and oncogenesis.6 Furthermore, 
melatonin was attested to be a potent free radical 
scavenger and a broad-spectrum antioxidant.6,7 
Melatonin is broadly available, relatively free of 
side effects, rapidly active after oral taking, and 
commonly used in humans in the treatment of 
insomnia. The melatonin function upon the kidney 
has been demonstrated by various experimental 
and human researches.6,7 Melatonin seems to 
act through multiple pathways: as an apoptosis 
modulator, as an antioxidant, and as a circadian 
modulator of vascular function. Melatonin is 
capable of abolishing the renal toxicity induced by 
some medications that may cause oxidative stress 
in kidney cells, including cisplatin, gentamicin, 
vancomycin and amikacin.6,7 Considering the 
safety profile of melatonin and its ability to reduce 
renal injury due to some other nephrotoxic drugs, 
this investigation was designed to test whether 
melatonin would protect against the nephrotoxicity 
induced by contrast media.
METHODS
Design and Setting:  In this study, we conducted 
an experimental design in laboratory setting of 
the Shahrekord University of Medical Sciences 
to identify the effect of melatonin against the 
nephrotoxicity of contrast media.  The present 
study was conducted in time period of 9 months 
in 2012 and included 40 adult male Wistar rats (six 
weeks old) with a mean body weight of 200-250g. 
Estimated required sample size for one- sample 
comparison of mean to hypothesized value with 
alpha 0.05 (Two-sided), power 0.95, mean and 
standard deviation 25(4) was 9 samples in each 
group. To elevate precision, we selected 10 samples 
in each groups.
 The rats were designated randomly into four 
equal groups as follow:
Group I: control group (sham group); they did not 
receive any drugs.
Group II: contrast media group; they received 
iodixanol 10 ml/kg/single dose by i.v. injection.
Group III: contrast media and melatonin; rats in 
this group, first received iodixanol 10 ml/kg/single 
dose by i.v. injection, then they  were treated with 
melatonin 10 ml/kg/day by i.p. injection on days 
3, 4 and 5.
Group IV: melatonin and contrast media group; rats 
in this group were pretreated with melatonin 10 
ml/kg/day by i.p. injection on days 1, 2 and 3, then 
they received iodixanol 10 ml/kg by i.v. injection.
Experimental study protocol: The experiment 
protocol was approved by Ethical Committee of 
Shahrekord University of Medical Sciences (Ethical 
Code No: 91/11/1). All rats were given unlimited 
access to standard rat chow and water. On the first 
day, blood samples (1ml) were collected from the 
lateral tail vein for examination of creatinine (Cr) 
and blood urea nitrogen (BUN) levels. After 20 
minurtes, rats of group IV were given 10 ml/kg of 
melatonin by daily i.p. injection for 3 days. On the 
third day, 10 ml/kg contrast media was injected to 
animals in the groups II and IV via the lateral tail 
vein. After 20 minutes rats of group III were given 
10 mg/kg of melatonin by i.p. injection daily for 3 
days. On the fifth day, all rats were anesthetized 
and the blood samples were collected for evaluation 
of Cr and BUN levels and then all rats were killed 
using ketamin.
 The kidneys were dissected out immediately after 
sacrificing and fixing with 10% formalin for histo-
logical examinations. The kidney paraffin sections 
(2-3 µm-thick) were prepared by a microtome and 
stained with hematoxylin and Eosin (H&E) for his-
tological examinations. H&E stained sections were 
evaluated by light microscope for severity of renal 
injury (degeneration, vacuolization of tubular re-
nal cells, dilatation of tubular lumen and presence 
of debris in the lumens), using conventional pro-
tocol.8,9 The slides were coded and evaluated by a 
nephropathologist who was blinded to the animal 
groups. Each morphologic lesion was scored from 
one to four, while the score zero was assigned to the 
normal tissue without any pathological damage. 
Therefore, score zero was considered as normal, 
   Pak J Med Sci   2014   Vol. 30   No. 2      www.pjms.com.pk   263
score one: 0-19% involvement, score two: injury 20-
49%, score three; 50-69% and score four; 70-100% 
damage.8,9
Data analysis: All parameters were summarized 
with mean and standard deviation. One-way Anal-
ysis of Variance (ANOVA) and post hoc tests (Bon-
ferroni Test) were used for the comparison of Mean 
values between groups. P values of less than 0.05 
were assumed to be significant (P<0.05).  To calcu-
late sample size and data analysis stata software 
was used.
RESULTS
 There was no difference in creatinine or BUN 
level between groups at the start of the experiment 
(Table-I). The changes in these parameters are 
shown in Table-II. Creatinine levels were not 
different between group I and group IV. However, 
creatinine levels were significantly higher in the 
group II compared to other groups (1.5 mg/dl. 
range 0.5 – 1.5, P=0.008). Although creatinine levels 
were higher in groups III and IV than in the control 
group, they were significantly lower than the level 
of group II. Creatinine level of the group III was 
higher than the group IV. BUN level was higher in 
the group II than in the other groups.
 Renal histological changes including 
degeneration, dilatation, debris and vacuolization 
were higher in the group II than in other groups. 
Renal injury scores in groups III and IV were higher 
than the ones in group I but lower than the score of 
the group II. The comparison between groups are 
shown in Table III.
DISCUSSION
 In this study we found the ameliorative effect 
of melatonin against CIN, through improvement 
of pathology damage scores in groups III and 
IV against group II. Serum creatinine level also 
supported the histopatologic findings. One of the 
interesting findings of this study was the lower 
serum creatinine of group IV in comparison to 
group III which supports the hypothesis that 
pretreatment with melatonin can abolish the 
kidney injury induced by contrast media. Kilic et 
al., investigated the underlying mechanism of the 
protective effect of melatonin against cisplatin-
induced renal damage in a rat renal-toxicity model 
in vivo. They found that both serum creatinine 
and urea nitrogen decreased significantly with 
melatonin co-treatment with cisplatin. They also 
demonstrated an improvement in histological 
lesions of cisplatin renal damage by melatonin co-
treatment.10 Ozguner et al. found that melatonin 
was capable of preventing renal tubular injury by 
reducing oxidative stress and protecting the kidney 
from oxidative damage induced by 900 MHz 
Table-I: Mean ±SD of creatinine and BUN of 
each group at the Start of the study.
Groups BUN Creatinine
 Mean Std. Dev. Mean Std. Dev.
Control  I 25.37 5 0.58 0.12
Contrast   II 24.75 5 0.68 0.3
Contrast+  25.37 4 0.68 0.3
  Melatonin  III
Melatonin,  25.37 5 0.67 0.31
  then Contrast IV
Total 25.21 4.6 0.65 0.26
F (ANOVA) 0.03 0.25
P Value 0.99 0.075
Table-II: Mean ±SD of BUN, creatinine and score levels of each group at the end of the study.
Groups BUN Creatinine Score
 Mean Std. Dev. Mean Std. Dev. Mean Std. Dev.
Control  I 25.62 4.9 0.58 0.11 3.12 1.4
Contrast   II 26.25 1.9 1.58 0.12 48.12 4.7
Contrast+ Melatonin  III 25.62 6 0.81 0.14 40.5 4.8
Melatonin, then Contrast IV 19.37 3.1 0.65 0.11 43.37 22.4
 24.218 4.9 0.90 0.42 33.78 21.3
Table-III: Comparison of BUN, creatinine and 
score levels between groups at the end of study.
Between Groups BUN Creatinine Score
comparison
I v.s II 0.62 P>0.05 1 P=0.001* 45 P=0.001*
I v.s III 0 P>0.05 0.23 P=0.008* 37.4 
   P=0.001*
I v.s IV 6.3 P= 0.04* 0.07 P=0.06 40.3 
   P=0.001*
II v.s III 0.62 P>0.05 0.78 P=0.001* 7.6 P>0.05
II v.s IV 6.8 P= 0.02* 0.93 P=0.001* 4.7 P>0.05
III v.s IV 6.2 P= 0.04* 0.16 P=0.09 2.8 P>0.05
* P values of less than 0.05 were assumed to be significant 
(P<0.05).
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mobile phone.11 Likewise, in the study conducted 
by Zararsiz et al. the protective effect of melatonin 
against formaldehyde-induced renal damage 
in rats was investigated. In light microscopic 
evaluation of the renal tissue, they observed that 
melatonin was able to prevent formaldehyde-
induced oxidative renal damage in rats.12 Recently, 
Lee et al. investigated the ameliorative effect 
of melatonin against gentamicin-induced renal 
toxicity and oxidative stress in rats.13 They also 
tested the effects of melatonin on induction of 
apoptotic cell death and its potential mechanisms in 
kidney tissue in response to gentamicin treatment. 
They observed that melatonin was able to protect 
kidney tissue against the oxidative damage and 
the nephrotoxic effect caused by gentamicin 
treatment.13 Moreover, histopathological 
evaluation confirmed the kidney protective effect 
of melatonin. They concluded that melatonin 
was capable of preventing renal toxicity induced 
by gentamicin through its potent antioxidant 
capability.13 CIN is one of the most common reasons 
of acute kidney injury in hospitalized patients.14 
It increases long-term morbidity and mortality 
and extend the hospital stay.14 No effective 
treatment exists for this iatrogenic disease; thus, 
prevention remains the key strategy.14 Studies 
have also shown that infusion of contrast agents 
increases osmotic load, viscosity, renal free radical 
production through post-ischemic oxidative stress 
and hypoxemia of the renal medulla.14 However, 
the exact mechanism of CIN is not fully clarified. 
Contrast agents have direct toxic effects on renal 
tubular cells and renal hemodynamics, directing 
to selective diminution of outer medullary blood 
flow.1-4,14 Various studies, have shown that oxygen 
radicals play a major causative role as the primary 
physiological insult.15-19 Infusion of contrast 
materials with the resultant increase in osmotic 
load and viscosity, increases hypoxemia of the 
renal medulla and renal free radical production 
through post-ischemic oxidative stress.14 This is 
due to decreased tissue oxygen tension which 
promotes mitochondrial generation of ROS.14 ROS 
have been increasingly accused as the mediators 
of injury in ischemic, toxic, and immune-mediated 
tissue damages. Melatonin activates several 
antioxidant enzymes, modulates gene expression 
for several protective enzymes and reduces lipid 
peroxidation.19,20
 Free radicals are chemical constituents that have 
an unpaired electron.21-24 When an electron is added 
to O2 then the superoxide anion radical “.O2-” is 
formed. “.O2-” is reduced by superoxide dismutase 
to H2O2 which is toxic at high concentrations and 
can be reduced to “.OH”. The hydroxyl radical (.OH) 
damages cells.22-24 Melatonin efficiently neutralizes 
the hydroxyl radical (.OH).25 Moreover, melatonin 
has been found to be effective in defending against 
severe free radical-mediated toxicity in a variety of 
conditions including: ischemia-reperfusion injury, 
acute kidney injury, chemotherapy, nitrogen 
mustard toxicity caused by mercuric chloride 
and gentamycin.6,7,25 In our study, melatonin was 
also capable of attenuating the CIN, which is in 
agreement with some other studies which have 
used other nephrotoxic agents.11-13 In fact melatonin 
is a safe drug6,7,25 and we recommend its use in high 
risk patients scheduled to apply contrast agent.
CONCLUSION
 Melatonin is an effective drug to attenuate 
contrast–induced renal injury.
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